Atrion (ATRI)
搜索文档
Atrion's (ATRI) Q2 Earnings Plummet Y/Y on Nordson Merger Costs
ZACKS· 2024-08-10 02:20
Atrion Corporation (ATRI) reported earnings per share (EPS) of 23 cents for the second quarter of 2024, a significant decline from the $3.73 reported in the year-ago period. Revenues for the second quarter of 2024 totaled $48.8 million, reflecting an 11% increase compared to $43.8 million in the same quarter of 2023. Atrion saw strong revenue growth, driven by increased sales across several product lines. Atrion's second-quarter 2024 performance presents a mixed picture. While the company delivered strong r ...
Atrion (ATRI) - 2024 Q2 - Quarterly Report
2024-08-09 06:30
财务表现 - 公司营收为4,877.3万美元,同比增长11.3%[108] - 毛利率从39.4%下降至32.5%,主要由于制造成本上升导致毛利下降[113] - 运营费用增加540万美元,主要由于并购相关的法律和财务顾问费用[114] - 运营利润从1,680万美元下降至50万美元,下降92.8%[115] 现金流和财务状况 - 现金及现金等价物、短期和长期投资合计为2,320万美元[130] - 经营活动产生的现金流为2,250万美元,主要来自净收益和存货减少[131] - 公司有2,500万美元的可用信贷额度,财务状况良好[129] 并购情况 - 公司已与Nordson公司达成并购协议,每股以460美元现金收购[103,104] - 公司已向SEC提交并购的代理投票声明[106] 业务表现 - 流体输送、心血管和其他产品线收入均有增长,但眼科产品收入下降40.0%[108,110] COVID-19影响 - 公司认为COVID-19对业务的影响已大幅减弱,但仍存在不确定性,尤其是对全球经济、供应链和医疗系统的干扰[134] - 公司将继续监测COVID-19及其引发的立法和监管变化,以管理应对并评估和努力减轻对业务的潜在不利影响[134] 会计准则变化 - 公司相信最近由财务会计准则委员会或其他标准制定机构发布的尚未生效的会计准则不会在采用时对其合并财务报表产生重大影响[136] 内部控制 - 公司正在实施控制和程序改进措施以解决所描述的重大弱点[136]
Atrion (ATRI) - 2024 Q2 - Quarterly Results
2024-08-09 06:00
财务业绩 - 公司第二季度收入为4,877.3万美元,同比增长11%[2] - 公司2024年上半年收入为9,610.7万美元,同比增长14.6%[7] - 公司第二季度净利润为40.2万美元,同比下降93.9%[8] - 公司第二季度每股摊薄收益为0.23美元,同比下降93.8%[9] - 剔除合并费用影响,公司第二季度营业利润为553.4万美元,同比下降25%[20] 业务表现 - 公司MPS控制台销售增长22%,MPS一次性耗材销售增长21%[3] - 公司流体输送产品持续复苏,部分产品系列收入同比实现两位数增长[3] - 公司为减少2023年供应链中断导致的库存积压,暂停了部分流体输送生产线,导致营业利润受到负面影响[3] 财务状况 - 截至2024年6月30日,公司现金及短期和长期投资总额为2,320万美元,无债务[4] 其他 - 公司宣布与Nordson公司合并的相关费用5,000万美元对本季度营业利润产生重大影响[3,20]
Atrion Reports Second Quarter 2024 Results
GlobeNewswire News Room· 2024-08-09 06:00
ALLEN, Texas, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced its results for the second quarter ended June 30, 2024. Revenues for the second quarter of 2024 totaled $48.8 million compared to $43.8 million for the same period in 2023. For the just ended quarter, operating income was $0.5 million, down $6.8 million from the comparable 2023 period, and net income was $0.4 million, down $6.2 million from the same period in 2023. Operating income was significantly impacted by ...
ATRI ALERT: The M&A Class Action Firm Investigates the Merger and August 19, 2024 Shareholder Vote of Atrion Corporation
Prnewswire· 2024-07-29 21:17
NEW YORK, July 29, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Atrion Corp. (Nasdaq: ATRI), relating to its proposed merger with Nordson Corporation. Under the terms of the agreement, Atrion Corp. shareholders will receive $460.00 in cash per share of At ...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ATRI, HTLF on Behalf of Shareholders
GlobeNewswire News Room· 2024-07-18 05:29
文章核心观点 - 该文章报道了两家公司的并购交易 [1][2] - 分别为Atrion Corporation被Nordson Corporation以每股460美元现金收购 [1] - 以及Heartland Financial, USA Inc.被UMB Financial Corporation以每股0.55股UMB普通股收购 [2] Atrion Corporation并购 - Atrion Corporation被Nordson Corporation以每股460美元现金收购 [1] - 如果您是Atrion的股东,可以了解您的法律权利和选择 [1] Heartland Financial, USA Inc.并购 - Heartland Financial, USA Inc.被UMB Financial Corporation以每股0.55股UMB普通股收购 [2] - 交易完成后,原Heartland股东预计将占合并后公司约31%的股份 [2] - 如果您是Heartland的股东,可以了解您的权利和选择 [2] 其他 - 律师事务所Halper Sadeh LLC可能会寻求为股东获得更高的对价、更多交易信息披露或其他利益 [3] - 该律师事务所以或有费用的方式处理此类案件,股东无需承担法律费用 [3] - 鼓励股东免费联系该律师事务所,了解自己的法律权利和选择 [4] - 该律师事务所代表全球受证券欺诈和公司不当行为影响的投资者 [5]
URGENT UPDATE: The M&A Class Action Firm Investigates Merger and Imminent Vote on August 19, 2024, of Atrion Corporation – ATRI
GlobeNewswire News Room· 2024-07-17 05:08
NEW YORK, July 16, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Atrion Corp. (Nasdaq: ATRI), relating to its proposed merger with Nordson Corporation. Under the terms of the agreement, Atrion Corp. shareholders will receive $460.00 in cash per share o ...
URGENT UPDATE: The M&A Class Action Firm Investigates Merger and Imminent Vote on August 19, 2024, of Atrion Corporation - ATRI
Prnewswire· 2024-07-16 08:36
NEW YORK, July 15, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Atrion Corp. (Nasdaq: ATRI), relating to its proposed merger with Nordson Corporation. Under the terms of the agreement, Atrion Corp. shareholders will receive $460.00 in cash per share of At ...
SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates Merger of Atrion Corporation – ATRI
GlobeNewswire News Room· 2024-07-09 03:13
NEW YORK, July 08, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Atrion Corp. (Nasdaq: ATRI), relating to its proposed merger with Nordson Corporation. Under the terms of the agreement, Atrion Corp. shareholders will receive $460.00 in cash per share o ...
Zacks Initiates Coverage of Atrion With Neutral Recommendation
ZACKS· 2024-06-07 20:46
Zacks Investment Research has recently initiated coverage of Atrion Corporation (ATRI) with a Neutral recommendation. The research report on Atrion, a Texas-based developer and manufacturer of medical devices, provides an in-depth analysis of the company’s financial health, market opportunities and potential risks, aiming to offer investors a balanced perspective on the stock.Atrion reported an 18.4% increase in revenue for Q1 2024, reaching $47.3 million. This growth was driven by a notable 27.8% year-over ...